Cryoport (CYRX) CEO Jerrell Shelton sells 28,800 shares under 10b5-1 plan

Rhea-AI Filing Summary

Cryoport, Inc. director and President/CEO Jerrell Shelton reported selling 28,800 shares of common stock on August 11, 2026 at a weighted average price of $14.9092 per share. The sale occurred automatically under a Rule 10b5-1 trading plan adopted on May 11, 2026 and terminated on August 11, 2026. Following this transaction, Shelton directly held 1,201,814 shares of Cryoport common stock.

Insider Trade Summary 10b5-1

Net Seller: 28,800 shares

Net Sell 1 txn

Insider SHELTON JERRELL

Role President, CEO

Sold 28,800 shs ($429K)

Type	Security	Shares	Price	Value
Sale	Common Stock F1, F2	28,800	$14.9092	$429K

Holdings After Transaction: Common Stock — 1,201,814 shares (Direct)

Footnotes (2)

1. F1. The transactions reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 11, 2026. The Rule 10b5-1 trading plan was terminated on August 11, 2026.
2. F2. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.66 to $15.16, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Key Figures

Shares sold: 28,800 shares Weighted average sale price: $14.9092 per share Post-transaction holdings: 1,201,814 shares +3 more

6 metrics

Shares sold 28,800 shares Common stock sale on August 11, 2026 by President/CEO Jerrell Shelton

Weighted average sale price $14.9092 per share Weighted average price for the 28,800 common shares sold

Post-transaction holdings 1,201,814 shares Direct common stock ownership by Jerrell Shelton after the reported sale

Price range of sales $14.66 to $15.16 per share Multiple transactions executed within this price range on August 11, 2026

Rule 10b5-1 plan adoption date May 11, 2026 Date Jerrell Shelton adopted the automatic trading plan for these transactions

Rule 10b5-1 plan termination date August 11, 2026 Date the trading plan governing the reported sale was terminated

Key Terms

Rule 10b5-1 trading plan, weighted average price, Form 4, open market or private transaction

4 terms

Rule 10b5-1 trading plan regulatory

"occurred automatically pursuant to a Rule 10b5-1 trading plan adopted"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

weighted average price financial

"The price reported is a weighted average price. These shares were sold"

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

Form 4 regulatory

"The transactions reported in this Form 4 occurred automatically"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

open market or private transaction market

"Sale in open market or private transaction"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/11/2026 - 06:50 PM Accepted by SEC EDGAR 08/11/2026 - 06:49 PM Learn about SEC filing dates

FAQ

What insider transaction did Cryoport (CYRX) report for Jerrell Shelton?

Cryoport reported that President and CEO Jerrell Shelton sold 28,800 shares of common stock on August 11, 2026 at a weighted average price of $14.9092 per share, under a pre-arranged Rule 10b5-1 trading plan.

How many Cryoport (CYRX) shares does Jerrell Shelton hold after this Form 4 sale?

After the reported sale, Jerrell Shelton directly held 1,201,814 shares of Cryoport common stock. This figure reflects his post-transaction direct ownership as disclosed, and does not address any other potential indirect or derivative holdings.

Was the Cryoport (CYRX) insider sale by Jerrell Shelton done under a Rule 10b5-1 plan?

Yes. The filing states the transactions occurred automatically under a Rule 10b5-1 trading plan adopted on May 11, 2026, which was terminated on August 11, 2026 after these trades.

At what prices were Jerrell Shelton’s Cryoport (CYRX) shares sold on August 11, 2026?

The reported weighted average price was $14.9092 per share. The shares were sold in multiple transactions at prices ranging from $14.66 to $15.16, and detailed trade breakdowns are available on request as noted in the disclosure.

How many Cryoport (CYRX) shares did Jerrell Shelton sell in this Form 4 filing?

Jerrell Shelton sold 28,800 shares of Cryoport common stock in this transaction. The sale is classified with code “S”, indicating a sale in an open market or private transaction, and is reported as a direct ownership transaction.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

SHELTON JERRELL

(Last) (First) (Middle)

C/O CRYOPORT INC.

112 WESTWOOD PLACE, SUITE 350

(Street)

BRENTWOOD TENNESSEE 37027

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Cryoport, Inc. [ CYRX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President, CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/11/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/11/2026		S(1)		28,800	D	$14.9092(2)	1,201,814	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The transactions reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 11, 2026. The Rule 10b5-1 trading plan was terminated on August 11, 2026.

2. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.66 to $15.16, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

	/s/ Jerrell Shelton	08/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)